Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

This study is testing whether a supervised nutrition and exercise program can help prevent or reverse a condition called "obese frailty" — a combination of excess weight and physical weakness — that commonly develops in prostate cancer survivors receiving hormone-blocking therapy (androgen deprivation therapy or ADT). ADT can cause muscle loss, weight gain, and fatigue over time, and this trial tests whether targeted lifestyle intervention can counter those effects. **You may be eligible if...** - You have been diagnosed with prostate cancer of any stage or grade - You are currently on or have been prescribed continuous hormone-blocking therapy (ADT) for less than 5 years - Your blood counts and organ function are within acceptable ranges **You may NOT be eligible if...** - You have severe bone disease or other conditions that make exercise unsafe - You have uncontrolled medical conditions preventing participation - You are already enrolled in a structured supervised exercise program Talk to your doctor to see if this trial is right for you.